FDA Adverse Event Malfunction Summary report: N

ILLUMISITE

MDR report key: 21027548 · Received December 27, 2024

Report

Report Number
3004962788-2024-00151
Event Type
Malfunction
Date Received
December 27, 2024
Date of Event
December 5, 2024
Report Date
March 14, 2025
Manufacturer
COVIDIEN LP - SUPERDIMENSION INC
Product Code
JAK
PMA / PMN Number
K191394
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
EZ
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: G3, H3, H6 H3 EVALUATION SUMMARY: MEDTRONIC CONDUCTED AN INVESTIGATION BASED UPON ALL INFORMATION RECEIVED. THE DEVICE WAS AVAILABLE FOR EVALUATION. THE EVALUATION FOUND REGISTRATIONS ERRORS IN THE LOGS, BUT THE SYSTEM WAS WORKING PROPERLY. IT WAS REPORTED THAT THERE WAS A REGISTRATION ISSUE. THE REPORTED ISSUE WAS CONFIRMED. THE MOST LIKELY CAUSE COULD NOT BE ESTABLISHED FROM THE INFORMATION AVAILABLE. THE MANUFACTURING RECORDS FOR EACH DEVICE ARE THOROUGHLY REVIEWED PRIOR TO RELEASE TO ENSURE THAT IT MEETS ALL MEDTRONIC QUALITY SPECIFICATIONS. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: B5, G3, H6 (FDR - C100205). MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: B3, B5, G3, H3. CORRECTION: E1 (FIRST NAME, LAST NAME, PHONE NUMBER), E3, E4 (EMAIL). MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING THE PROCEDURE, IN THE AUTOMATIC NAVIGATION PROCESS OF THE PRODUCT NONE OF THE LANDMARKS COULD BE REGISTERED EXCEPT FOR THE RIGHT LOWER LOBE, INDICATING A REGISTRATION ISSUE. THERE WAS NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THE ISSUE. UPON SERVICING, THE UNIT WAS CLEANED. PREVENTATIVE MAINTENANCE DONE AND PASSED. THE UNIT CAN BE FULLY USED.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING THE PROCEDURE, IN THE AUTOMATIC NAVIGATION PROCESS OF THE PRODUCT NONE OF THE LANDMARKS COULD BE REGISTERED EXCEPT FOR THE RIGHT LOWER LOBE, INDICATING A REGISTRATION ISSUE. THE PHYSICIAN WAS ABLE TO COMPLETE THE SUPERDIMENSION PORTION OF THE CASE. THERE WAS NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THE ISSUE. UPON SERVICING, THE UNIT WAS CLEANED. PREVENTATIVE MAINTENANCE DONE AND PASSED. THE UNIT CAN BE FULLY USED.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING THE PROCEDURE, IN THE AUTOMATIC NAVIGATION PROCESS OF THE PRODUCT, NONE OF THE LANDMARKS COULD BE REGISTERED EXCEPT FOR THE RIGHT LOWER LOBE, INDICATING A REGISTRATION ISSUE. THERE WAS NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THE ISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2496349 ILLUMISITE SYSTEM, X-RAY, TOMOGRAPHY, COMPUTED JAK COVIDIEN LP - SUPERDIMENSION INC ILS-1000-CS

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown